发表学术论文68篇（略），负责或参加科研项目17项，获得专利3项。
课题如：国家重点基础研究发展计划（973计划）：从骨质疏松症探讨“肾主骨”理论的研究（课题编号：2010CB530404）。子项目负责人，
上海市教委：从调控巨噬细胞活化角度探讨祛瘀生新法对溃疡性结肠炎免疫调节的作用机理。批准号：09YZ127。第三完成人。2009.1-2011.12
国家自然科学基金：补肾中药调节成骨细胞和软骨细胞功能的规律研究.批准号：81173312。2012.1-2015.12。第一负责人，
上海市卫生局：从胰岛素抵抗角度探讨化瘀解毒法对MCI疗效研究（课题编号：2012L005A）。第一负责人。
中华医学会医学教育分会、中国高等教育学会医学教育专业委员会：模拟契约服务在全科医生规范化培训中的应用探索。批准号：2012-QK-11。
美高梅：《全科医学概论》课程的优化与实践。2013.
杨浦区卫生与计划生育委员会：全科医师中医药应用能力培养及mini- CEX效果评估研究
国家自然科学基金：基于TSLP/DC/OX40L通路探讨补肾益气药预防支气管哮喘的疗效和机制。2016.1-2018.12。批准号：81503483，第三负责人。
Published 68 (abbreviated), responsible for or participate in the 17 research projects, obtained 3 patents.
Research topics such as:
The national basic research program (973 Program): from osteoporosis to discuss "the kidney dominates bone," theoretical study (project number: 2010CB530404). Project Manager,
Shanghai Municipal Education Commission: from the regulation of macrophage activation point of stasis-new law on immunomodulatory mechanism of ulcerative colitis. Approval number: 09YZ127. the third completed member. 2009.1-2011.12
National Natural Science Foundation: kidney-tonifying traditional Chinese medicine regulating function of Osteoblast and chondrocyte study. approval number: 81173312. 2012.1-2015.12. The head .
Shanghai Municipal Health Bureau: from the perspective of insulin resistance of MCI study on effect of Huayu jiedu method (topic number: 2012L005A). the Head.
Medical education branch of the Chinese Medical Association, the China Association of higher education professional Committee of medical education: the analog contract services application in standardized training of general practitioners. Approval number: 2012-QK-11. The head.
Tongji University: optimization of the course Introduction to family medicine and practice. 2013. The head.
Yangpu District Committee on health and family planning: general practitioners of traditional Chinese medicine application of capacity-building and mini-CEX effects evaluation .
National natural science Fund: discussion on TSLP/DC/OX40L path of reinforcing kidney, replenishing qi to prevent bronchial asthma curative effect and mechanism. 2016.1-2018.12. Approval number: 81503483, the third aplier.
专利名称：
一种治疗代谢综合征的纯中药组合物及由其制备的纯中药制剂（授权公告号：CN101884678B）
治疗慢性肠功能紊乱的纯中药组合物及由其制备的纯中药外用粉贴剂（授权公告号：CN102805794B）
治疗老年骨质疏松症的纯中药配方及其免煎颗粒剂（授权公告号：CN102139007B）
Patent name:
a treatment metabolism integrated levy of pure medicine combination real and the by its preparation of pure medicine preparations (authorized announcement,: CN101884678B)
treatment chronic intestinal function disorder of pure medicine combination real and the by its preparation of pure medicine topical powder posted agent (authorized announcement,: CN102805794B)
treatment aged osteoporosis syndrome of pure medicine formula and from fried particles agent (authorized announcement,: CN102139007B)
